Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, Inc. (SRPT), sold 20,000 shares at $158.95 ($3.2M) on 2020-08-10, disclosed to the SEC on 2020-08-11.
Open-market sale of $3.2M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.95 | 9,223 | $1.5M | 46.1% |
| 2 | $158.95 | 9,223 | $1.5M | 46.1% |
| 3 | $159.65 | 777 | $124K | 3.9% |
| 4 | $159.65 | 777 | $124K | 3.9% |
| Total | $159.00 avg | 20,000 | $3.2M | 100% |
| Filing → |
| SRPT | SELL | 2023-08-08 | $1.6M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $835K | — | Filing → |
| SRPT | SELL | 2020-05-22 | $1.2M | — | Filing → |